Gapping up: In reaction to strong earnings/guidance: RSH +18.4%, PTV +16.7%, AN +15.2% (light volume), MCRI +13.9% (light volume), RCL +13.1%, IRBT +12.2%, DAVE +11.9%, FITB +11.7%, NUVA +10.7%, WGOV +10.6% (also upgraded to Outperform at Baird), JBLU +10.2%, RTN +10.2%, CMG +9.9%, CNX +9.8%, TASR +9.6%, GRT +7.5% (light volume), LCC +6.0%, TQNT +5.8% (light volume), MI +5.7%, EBAY +5.4%, PNC +5.1%, YUM +5.0%, MAR +4.8% (light volume), NVS +4.7%, QCOM +4.2% (Revenue and operating income for the second quarter of fiscal 2009, excluding the potential impact of the Broadcom agreement, met or exceeded prior guidance), HSY +4.1%, COP +4.0%, NE +4.0%, NVLS +3.9%, XLNX +3.9%, DO +3.7%, AAPL +2.9% (upgraded to Outperform at Morgan Keegan), CKH +2.6%... Select financial related names trading higher: CS +11.2% (flies above forecast on big trading gain - Reuters), RF +7.8%, FIG +7.3%, ING +7.1%, BCS +6.3% (Chairman says no intention to raise more capital - DJ), IBN +6.0%, GNW +5.3%, DB +5.0%, WFC +4.0%, FMER +3.9% (Cramer makes positive comments on MadMoney), BAC +3.4%, USB +2.5%, C +2.2%, MS +1.6% (upgraded to Neutral at BofA/Merrill), JPM +1.4%, GS +1.3%... Select metals/mining names showing strength: RTP +5.1%, MT +3.3%, BHP +1.9%... Select oil/gas names trading higher: E +3.2%, TOT +3.1%, BP +2.9% (upgraded to Buy at RBS), RDS.A +2.1%... Other news: ABMD +26.1% (receives FDA 510(k) clearance for Impella 5.0 and Impella LD), ACOR +14.5% (resubmits new drug application for Fampridine-SR for improvement of walking ability in people with multiple sclerosis), LVS +8.8% (still checking), MICC +8.8% (still checking), BRCM +8.4% (Qualcomm reschedules earnings release due to settlement discussions with Broadcom; also upgraded to Market Perform at JMP), DRYS +5.4% (still checking), NOK +3.8% (still checking), NDAQ +3.3% (announces March 2009 stats)... Analyst comments: EBAY +6.6% (upgraded to Hold at Collins Stewart), TIN +4.3% (upgraded to Buy from Neutral at Goldman- Reuters), BRCD +3.6% (upgraded to Buy at Jefferies).
AI
